Market research
PNV.AU PolyNovo Limited
AU AUD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 684M
- P/E ratio
- 99.0
- Analyst target
- 1.2473
- Dividend yield
- Not available
- Beta
- 1.36
Community
Investor discussion
1 comment
Sign in to join the PNV.AU discussion.
5 years, 5 months ago
PolyNovo Limited is currently in a long term downtrend where the price is trading 15.2% below its 200 day moving average.
From a valuation standpoint, the stock is 70.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 76.9.
PolyNovo Limited's total revenue rose by 25.3% to $13M since the same quarter in the previous year.
Its net income has dropped by 46.3% to $-4M since the same quarter in the previous year.
Finally, its free cash flow grew by 58.9% to $-2M since the same quarter in the previous year.
Based on the above factors, PolyNovo Limited gets an overall score of 3/5.